Over the years the Group has successfully conducted a number of studies in collaboration with both the WHO Essential Medicines and Pharmaceutical Policies in Geneva and the Regional Office for Europe in Copenhagen. These include analyses of the pharmaceutical sector in Estonia and Moldova (2012, 2014) and options for financing and optimizing medicines in resource poor settings, the results of which fed into the World Health Report 2011. Further, MTRG has participated in policy dialogue meetings lending its longstanding experience in the field to offer advice to Governments on viable policy options to improve quality, availability and affordability of medicines.
For further information please contact: Alessandra Ferrario (a.ferrario@lse.ac.uk), Panos Kanavos (p.g.kanavos@lse.ac.uk)